Articles Posted in the Medical fraud Category


    Serono, which is based in Geneva, pleaded guilty in a Boston court to criminal conspiracy charges in relation to its Aids treatment drug Serostim. In 1996 the Food and Drug Administration approved Serostim for use in treating Aids wasting, an often-fatal condition involving severe weight loss. Serostim, which contains the human growth hormone Somatropin, came […]

  • U.K.Government’s £80m for victims of thalidomide – but still no apology

    Survivors in England of the world’s worst drug disaster, which led to the birth of 10,000 grossly disfigured children worldwide, are to receive £80m in compensation from the Government to help with their increasing needs. The cash, to be paid over 10 years, will be divided between 325 of the victims of thalidomide, a drug […]

  • Thousands of Mistakes Made in Surgery Every Year

    More than 4,000 preventable mistakes occur in surgery every year at a cost of more than $1.3 billion in medical malpractice payouts, according a new study. How preventable? Well, researchers call them “never events” because they are the kind of surgical mistakes that should never happen, like performing the wrong procedure or leaving a sponge […]

  • Roche Medicine Safety Reports

    In June the pharmaceutical company Roche came under fire. Fierce Pharma  reported that the European Medicines Agency is working with national medicines agencies to investigate deficiencies in the medicine-safety reporting system of Roche. According to the report this includes looking at whether the deficiencies have an impact on the overall benefit-risk profile for any of […]

  • Flu Vaccine Doubles Risk of More Serious Illness

    Flu Vaccine Doubles Risk of More Serious Illness Data collected from Canada and Hong Kong during 2009-2010 showed that people who received the seasonal flu vaccine in 2008 had twice the risk of getting the H1N1 “swine flu,” compared to those who hadn’t received a flu shot While the initial findings were largely discounted, new […]

  • Pre-diabetes is a new revenue stream for drug companies

    With the soaring number of people being diagnosed with pre-diabetes the implications of early and aggressive treatment with medication may be anything but a lifesaver for the patient, but is going to ensure than big pharma remains profitable. Always listen to the warning signs The marker for pre-diabetes is a glucose level higher than normal, […]

  • Amgen’s Anemia Drugs Aranesp and Epogen

      Amgen is accused in overfilling anemia  medicine Aranesp so that doctors could give the “free”medicines to patients and then bill insurance companies for it. In this case, drug makers worked hard to make sure that doctors give large doses so that the incentive was large. They offered discounts if the drug was used in large big volumes. […]

  • Abbott Labs fined $1.5 Billion as penalty for Off-label Promotion of Depakote

    Global Health Care Company Abbott Laboratories Inc. pleaded guilty and agreed to pay $1.5 billion to resolve  its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA). The FDA is responsible for approving drugs […]

  • Johnson & Johnson fined $1.1bn in Risperdal case

    Drugs giant Johnson & Johnson (J&J) was ordered to pay $1.1bn (£690m) for hiding the risks involved in taking its anti-psychotic drug Risperdal. Johnson and Johnson was sued for marketing the drug Risperdal in 2007. In January 1999, the Food & Drug Administration (‘FDA’) had warned J&J that marketing Risperdal as  safe and effective in […]

  • The truth behind world’s second largest pharmaceutical company

    Indian Pharmaceutical Market is projected to grow to 1366.09 hundred crores by 2015 and to 3124 hundred crore market by 2020,according to a report published in Wall Street Journal.The patient pool will rise by nearly 20%.Ofcourse the patient pool will rise.why not??When The worlds second largest company by sales which generates 7.6% of its revenue […]